We’re excited to announce that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, an affiliate company of T-E PHARMA, will be presenting at the Investment Summit Session of BIO Asia–Taiwan 2025 conference.
Time: 15:40-16:50 Roadshow, Wednesday, July 23, 2025
Venue: Room 701AB, 7F, TaiNEX2
Dr. Chu will share our latest breakthroughs in ADC product development and proprietary platform technology. This event offers a great opportunity to connect with industry leaders, investors and potential partners to explore strategic collaborations that drive innovation and improve patient outcomes.
If you’re attending, we’d love to connect and explore how we can innovate together!
